Daily Dose - Aug 25th, 2025
Daily Dose |
View online
August 25, 2025
ProBio is third company in recent years to make a go of New Jersey manufacturing site
The CDMO acquired the 128,000-square-foot cell and gene therapy facility in Hopewell last year, which is now ProBio’s North American hub.
Read More
Cambrex expands Massachusetts site to boost peptide manufacturing
The Snapdragon Chemistry facility expansion adds GMP capacity and supports multiple peptide synthesis approaches.
Read More
Adva, Autolomous launch program to digitize cell therapy manufacturing
The Digital Pioneer Program combines automation and digital tools to streamline autologous cell therapy production.
Read More